Prestige CEO Tightens Focus On OTCs, Considers Divesting Personal Care
This article was originally published in The Tan Sheet
Executive Summary
Prestige Brands Holdings may divest its entire personal care segment to sharpen its focus on OTC drug and household products, new CEO Matt Mannelly says
You may also be interested in...
Prestige Adds Little Fevers To Children's Liquid Pain Relief Competition
Prestige Brands Holdings extends its Little Remedies pediatric OTC line with a liquid acetaminophen product, becoming the latest firm to venture into the category Johnson & Johnson usually dominates
Prestige Adds Little Fevers To Children's Liquid Pain Relief Competition
Prestige Brands Holdings extends its Little Remedies pediatric OTC line with a liquid acetaminophen product, becoming the latest firm to venture into the category Johnson & Johnson usually dominates
Prestige Adds Little Fevers To Children's Liquid Pain Relief Competition
Prestige Brands Holdings extends its Little Remedies pediatric OTC line with a liquid acetaminophen product, becoming the latest firm to venture into the category Johnson & Johnson usually dominates